Dharam Ablashi

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 14:44, April 9, 2018 by Kmdenmark (talk | contribs) (reformatted study section and ref)
Source:LinkedIn

Dharam V. Ablashi, (b. 1931), DVM, MS, Dip. Bact. (Diploma in Bacteriology), Research Microbiologist, Head of DNA Viruses Section and Coordinator of DNA Viruses, National Cancer Institute.[1]

He co-discovered HHV-6 in 1986, while working at the National Cancer Institute at National Institutes of Health and is the Scientific Director of the HHV-6 Foundation and Chair of the Scientific Advisory Committee.[2]

Ablashi co-founded the American Association of CFS with Orvalene Prewitt, in 1990.[3] The organization has been renamed as the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis with Ablashi serving as a past President of the Board of Directors from 2003-2004.[4]

Awards[edit | edit source]

  • 2007, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FM scientist, physician or healthcare worker awarded by IACFS/ME[5]
  • 2007, Achievement Award from New Jersey CFS Association Inc.[6]

CFSAC Testimony[edit | edit source]

  • Written presentation at October 29, 2009:"It is imperative that the CDC study biopsy samples from the gut, and brain as well as heart tissues, and that they look at spinal fluid. Most of the studies done by the CDC have been on serum. However, many pathogens cannot be found in the serum because they do not circulate in the peripheral blood after the initial infection."[7]

Open Letter to The Lancet[edit | edit source]

Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Ablashi, along with 41 colleagues in the ME/CFS field, signed the second letter.

Notable Studies in ME/CFS[edit | edit source]

Online presence[edit | edit source]

Learn More[edit | edit source]

See Also[edit | edit source]

References[edit | edit source]

  1. ↑ https://visualsonline.cancer.gov/details.cfm?imageid=8202
  2. ↑ http://hhv-6foundation.org/about-us/scientific-director
  3. ↑ http://iacfsme.org/Organization/History-of-the-IACFS-ME.aspx
  4. ↑ http://iacfsme.org/Organization/Committees-of-the-IACFS-ME.aspx
  5. ↑ http://iacfsme.org/Organization/Former-IACFS-ME-Awardees.aspx
  6. ↑ https://en.wikipedia.org/wiki/Dharam_Ablashi
  7. ↑ http://www.hhs.gov/advcomcfs/meetings/presentations /ablashi_1009.pdf
  8. ↑ Cameron, Barbara; Hirschberg, David L.; Rosenberg-Hassan, Yael; Ablashi, Dharam; Lloyd, Andrew R. (2010), "Serum Cytokine Levels in Postinfective Fatigue Syndrome", Clinical Infectious Diseases, 50 (2): 278-280, doi:10.1086/649546
  9. ↑ Levine, Susan; Eastman, Helen; Ablashi, Dharam V. (2001), "Prevalence of IgM and IgG Antibody to HHV-6 and HHV-8 and Results of Plasma PCR to HHV-6 and HHV-7 in a Group of CFS Patients and Healthy Donors", Journal of Chronic Fatigue Syndrome, 9 (1–2): 31-40, doi:10.1300/J092v09n01_04
  10. ↑ Wagner, Mathias; Krueger, Gerhard R. F.; Ablashi, Dharam V.; Whitman, James E. (1996), "Chronic Fatigue Syndrome (CFS): A Critical Evaluation of Testing for Active Human Herpesvirus-6 (HHV-6) Infection, Review of Data of 107 Cases", Journal of Chronic Fatigue Syndrome, 2 (4): 3-16, doi:10.1300/J092v02n04_02
  11. ↑ Ablashi, Dharam V.; Ablashi, Kristine L.; Kramarsky, Bernhard; Bernbaum, John; Whitman, James E.; Pearson, Gary R. (1995), "Viruses and Chronic Fatigue Syndrome: Current Status", Journal of Chronic Fatigue Syndrome, 1 (2): 4-22, doi:10.1300/J092v01n02_02
  12. ↑ Strayer, DR; Carter, W; Strauss, KI; Brodsky, I; Suhadolnik, R; Ablashi, D; Henry, B; Mitchell, WM; Bastien, S; Peterson, D (1995), "Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen", Journal of Chronic Fatigue Syndrome, 1 (1): 35-53, doi:10.1300/J092v01n01_04
  13. ↑ Ablashi, DV; Berneman, ZN; Williams, M; Strayer, D; Kramarsky, B; Suhadolnik, RJ; Reichenbach, N; Hiltzges, P; Komaroff, AL (1994), "Ampligen inhibits human herpesvirus-6 in vitro", In Vivo, 8 (4): 587-91, PMID 7893986
  14. ↑ Buchwald, Dedra; Cheney, Paul R.; Peterson, Daniel L.; Henry, Berch; Wormsley, Susan B.; Geiger, Ann; Ablashi, Dharam V.; Salahuddin, S. Zaki; Saxinger, Carl; Biddle, Royce; Kikinis, Ron; Jolesz, Ferenc A.; Folks, Thomas; Balachandran, N.; Peter, James B.; Gallo, Robert C.; Komaroff, Anthony L. (1992), "A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection", Annals of Internal Medicine, 116 (2): 103-113, PMID 1309285
  15. ↑ Levine, Paul H.; Jacobson, Steven; Pocinki, Alan G.; Cheney, Paul; Peterson, Daniel; Connelly, Roger R; Weil, R; Robinson, SM; Ablashi, Dharam V; Salahuddin, Sayeef Z; Pearson, GR; Hoover, R (1992), "Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome", Archives of Internal Medicine, 152 (8): 1611-1616, doi:10.1001/archinte.1992.00400200049009

Chronic Fatigue Syndrome Advisory Committee (CFSAC) - (sometimes pronounced SIF-SACK) A US government advisory council that met twice per year, covering current topics related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Meetings usually lasted for two days and the results were presented to the Secretary of Health and Human Services (HHS). After 15 years, on September 5, 2018, CFSAC's charter was not renewed by the Department of HHS, effectively dissolving the committee without notice or warning.

Centers for Disease Control and Prevention (CDC) - The Centers for Disease Control and Prevention is a U.S. government agency dedicated to epidemiology and public health. It operates under the auspices of the Department of Health and Human Services.

serum The clear yellowish fluid that remains from blood plasma after clotting factors have been removed by clot formation. (Blood plasma is simply blood that has had its blood cells removed.)

serum The clear yellowish fluid that remains from blood plasma after clotting factors have been removed by clot formation. (Blood plasma is simply blood that has had its blood cells removed.)

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

plasma The liquid part of blood, lymph, or milk after removing any suspended material. Most of the time, "plasma" simply refers to blood, after all the blood cells have been removed. If you also remove the clotting factors, then the plasma is referred to as "serum".

cytokine any class of immunoregulatory proteins secreted by cells, especially immune cells. Cytokines are small proteins important in cell signaling that modulate the immune system. (Learn more: me-pedia.org)

Retrieved from "https://me-pedia.org/w/index.php?title=Dharam_Ablashi&oldid=28571"